Abstract
The adaptation of fully biodegradable stents, thought to be the next revolution in minimally invasive cardiovascular interventions, is supported by recent findings in cardiovascular medicine concerning human coronaries and the likelihood of their deployment has been made possible by advances in polymer engineering. The main potential advantages of biodegradable polymeric stents are: (1) the stent can degrade and transfer the load to the healing artery wall which allows favorable remodeling, and (2) the size of the drug reservoir is dramatically increased. The in-stent restenotic response usually happens within the first six months, thus a fully biodegradable stent can fulfill the mission of restoring flow while mitigating the probability of long-term complications. However, it is a key concern that the stent not degrade away too soon, or develop structural instabilities due to faster degradation in key portions of the stent. We present here a preliminary model of the mechanics of a loaded, biodegradable cylindrical structure. The eventual goal of this research is to provide a means of predicting the structural stability of biodegradable stents
As a first step towards a fully nonlinear model, biodegradable polymers are modeled as a class of linearized materials. An inhomogeneous field that reflects the degradation, which we henceforth refer to as degradation, and a partial differential equation governing the degradation are defined. They express the local degradation of the material and its relationship to the strain field. The impact of degradation on the material is accomplished by introducing a time-dependent Young’s modulus function that is influenced by the degradation field. In the absence of degradation, one recovers the classical linearized elastic model. The rate of increase of degradation was assumed to be dependent on time and linearized strain with the following characteristics: (1) a material degrades faster when it is exposed to higher strains, and (2) a material that is strained for a longer period of time degrades more rapidly than a material that has been strained by the same amount for a shorter period of time
The initial boundary value problem considered is that of an infinitely long, isotropic, nearly incompressible, homogeneous, and strain-degradable cylindrical annulus subjected to radial stresses at its boundaries. A semiinverse method assuming a specific form of the displacement field was employed and the problem reduced to two coupled nonlinear partial differential equations for a single spatial coordinate and time. These equations were solved simultaneously for the displacement and degradation fields using a time marching finite element formulation with a set of nonlinear iterations for each time step
The main features that were observed were: (1) strain-induced degradation showed acceptable phenomenological characteristics (i.e. progressive failure of the material and parametric coherence with the defined constants); (2) an inhomogeneous deformation leads to inhomogeneous degradation and therefore in an initially homogeneous body the properties vary with the current location of the particles; and (3) the linearized model, in virtue of degradation, exhibits creep, stress relaxation, and hysteresis, but this is markedly different from the similar phenomena exhibited by viscoelastic materials
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
[AGa] Agrawal, C.M., and Clark, H.G., Deformation characteristics of a bioabsorbable intravascular stent. Invest. Radiol., 27 (1992), 1020–1024.
Agrawal, C.M., Haas, K.F., Leopold, D.A., and Clark, H.G., Evaluation of poly(L-lactic acid) as a material for intravascular polymeric stents. Biomaterials, 13 (1992), 176–182.
Ahn, Y.K., Jeong, M.H., Kim, J.W., et al., Preventive effects of the heparin-coated stent on restenosis in the porcine model. Catheter Cardiovasc. Interv., 48 (1999), 324–330.
Al Suwaidi, J., Berger, P.B., and Holmes, D.R., Jr., Coronary artery stents. JAMA, 284 (2000), 1828–1836.
Ali, S.A., Doherty, P.J., and Williams, D.F., Mechanisms of polymer degradation in implantable devices. 2. Poly(DL-lactic acid). J. Biomed. Mater. Res., 27 (1993), 1409–1418.
Ali, S.A., Zhong, S.P., Doherty, P.J., and Williams, D.F., Mechanisms of polymer degradation in implantable devices. 1. Poly (caprolactone). Biomaterials, 14 (1993), 648–656.
Ardissino, D., Cavallini, C., Bramucci, E., et al., Sirolimus-eluting vs. uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial, JAMA, 292 (2004), 2727–2734.
Athanasiou, K.A., Agrawal, C.M., Barber, F.A., and Burkhart, S.S., Orthopaedic applications for PLA-PGA biodegradable polymers. Arthroscopy J. Arthroscopic Related Surg., 14 (1998), 726–737.
Axel, D.I., Kunert, W., Goggelmann, C., et al., Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation, 96 (1997), 636–645.
Babapulle, M.N., and Eisenberg, M.J., Coated stents for the prevention of restenosis: Part II. Circulation, 106 (2002), 2859–2866.
Bedoya, J., Meyer, C.A., Timmins, L.H., Moreno, M.R., and Moore, J.E., Jr., Effects of stent design parameters on artery wall mechanics (submitted).
Bellenger, V., Ganem, M., Mortaigne, B., and Verdu, J., Lifetime prediction in the hydrolytic aging of polyesters. Polym. Degradation Stability, 49 (1995), 91–97.
Bertrand, O.F., Sipehia, R., Mongrain, R., et al., Biocompatibility aspects of new stent technology. J. Am. Coll. Cardiol., 32 (1998), 562–571.
Bier, J.D., Zalesky, P., Li, S.T., Sasken, H., and Williams, D.O., A new bioabsorbable intravascular stent: in vitro assessment of hemodynamic and morphometric characteristics. J. Interv. CardioL, 5 (1992), 187–194.
Blindt, R., Hoffmeister, K.M., Bienert, H., et al., Development of a new biodegradable intravascular polymer stent with simultaneous incorporation of bioactive substances. Int. J. Artif. Organs, 22 (1999), 843–853.
Bose, S.M., and Git, Y., Mathematical modelling and computer simulation of linear polymer degradation: Simple scissions. Macromol. Theor. Simul., 13 (2004), 453–473.
Browarzik, D., and Koch, A., Application of continuous kinetics to polymer degradation. J. Macromol. Sci. Pure Appl. Chem., 33A (1996), 1633–1641.
Burkersroda, F.v., Schedl, L., and Gopferich, A., Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials, 23 (2002), 4221–4231.
Colombo, A., and Karvouni, E., Biodegradable stents: “Fulfilling the mission and stepping away.” Circulation, 102 (2000), 371–373.
Currier, J.W., and Faxon, D.P., Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J. Am. Coll. Cardiol., 25 (1995), 516–520.
De Scheerder, I.K., Wilczek, K.L., Verbeken, E.V., et al., Biocompatibility of biodegradable and nonbiodegradable polymer-coated stents implanted in porcine peripheral arteries. Cardiovasc. Intervent. Radiol., 18 (1995), 227–232.
De Scheerder, I.K., Wilczek, K.L., Verbeken, E.V., et al., Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries. Atherosclerosis, 114 (1995), 105–114.
DePalma, V.A., Baier, R.E., Ford, J.W., Glott, V.L., and Furuse, A., Investigation of three-surface properties of several metals and their relation to blood compatibility. J. Biomed. Mater. Res., 6 (1972), 37–75.
Di Mario, C., Griffiths, H., Goktekin, O., et al., Drug-eluting bioabsorbable magnesium stent. J. Interv. Cardiol., 17 (2004), 391–395.
Dotter, C.T., Transluminal angioplasty: A long view. Radiology, 135 (1980), 561–564.
Douglas, J.S., Jr., King, S.B., 3rd, and Roubin, G.S., Influence of the methodology of percutaneous transluminal coronary angioplasty on restenosis. Am. J. Cardiol., 60 (1987), 29B–33B.
Drumright, R.E., Gruber, P.R., and Henton, D.E., Polylactic acid technology. Adv. Mater., 12 (2000), 1841–1846.
Duda, S.H., Bosiers, M., Lammer, J., et al., Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: The SIROCCO II trial. J. Vasc. Interv. Radiol., 16 (2005), 331–338.
Duda, S.H., Pusich, B., Richter, G., et al., Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six-month results. Circulation, 106 (2002), 1505–1509.
Edelman, E.R., and Rogers, C., Pathobiologic responses to stenting. Am. J. Cardiol., 81 (1998), 4E–6E.
Farb, A., Weber, D.K., Kolodgie, F.D., Burke, A.P., and Virmani, R., Morphological predictors of restenosis after coronary stenting in humans. Circulation, 105 (2002), 2974–2980.
Faxon, D.P., Vascular stents. Rev. Cardiovasc. Med., 2 (2001), 106–107.
Fischell, TA., Polymer coatings for stents. Can we judge a stent by its cover? Circulation, 94 (1996), 1494–1495.
Fischman, D.L., Leon, M.B., Baim, D.S., et al., A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary-artery disease. N. Engl. J. Med., 331 (1994), 496–501.
Gallo, R., Padurean, A., Jayaraman, T., et al., Inhibition of intimai thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation, 99 (1999), 2164–2170.
Garlotta, D., A literature review of poly(lactic acid). J. Polym. Environ., 9 (2001), 63–84.
Glagov, S., Zarins, C.K., Masawa, N., Xu, CP., Bassiouny, H., and Giddens, D.P., Mechanical functional role of non-atherosclerotic intimai thickening. Front. Med. Biol. Eng., 5 (1993), 37–43.
Glagov, S., Intimai hyperplasia, vascular modeling, and the restenosis problem. Circulation, 89 (1994), 2888–2891.
Gopferich, A., and Langer, R., Modeling polymer erosion. Macromolecules, 26 (1993), 4105–4112.
Gopferich, A., Mechanisms of polymer degradation and elimination. In: Domb, A.J., Kost, J., and Wiseman, D.M., Eds. Handbook of Biodegradable Polymers. Harwood Academic, Australia (1997), 451–471.
Gopferich, A., Polymer degradation and erosion: Mechanisms and applications. Eur. J. Pharm. Biopharm., 4 (1996), 1–11.
Grabow, N., Martin, H., and Schmitz, K.P., The impact of material characteristics on the mechanical properties of a poly(L-lactide) coronary stent. Biomed. Tech. (Berl.), 47 (2002), 503–505.
Grabow, N., Schlun, M., Sternberg, K., Hakansson, N., Kramer, S., and Schmitz, K.P., Mechanical properties of laser cut poly(L-lactide) micro-specimens: Implications for stent design, manufacture, and sterilization. J. Biomech. Eng., 127 (2005), 25–31.
Grube, E., Gerckens, U., Muller, R., and Bullesfeld, L., Drug eluting stents: Initial experiences. Z. Kardiol., 91 (2002), 44–48.
Grube, E., Silber, S., Hauptmann, K.E., et al., TAXUS I: Sixand twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation, 107 (2003), 38–42.
Gutwald, R., Pistner, H., Reuther, J., and Muhling, J., Biodegradation and tissue-reaction in a long-term implantation study of poly (L-Lactide). J. Mater. Sci. Mater. Med., 5 (1994), 485–490.
Hawkins, W.L., Polymer degradation. In: Polymer degradation and stabilization. Springer-Verlag, Berlin (1984) 3–34.
Hayashi, T., Biodegradable polymers for biomedical uses. Prog. Polym. Sci., 19 (1994), 663–702.
Heublein, B., Rohde, R., Kaese, V., Niemeyer, M., Hartung W., and Haverich, A., Biocorrosion of magnesium alloys: A new principle in cardiovascular implant technology? Heart, 89 (2003), 651–656.
Hietala, E.M., Salminen, U.S., Stahls, A., et al., Biodegradation of the copolymeric polylactide stent. Long-term follow-up in a rabbit aorta model. J. Vasc. Res., 38 (2001), 361–369.
Holmes, D.R., Camrud, A.R., Jorgenson, M.A., Edwards, W.D., and Schwartz, R.S., Polymeric stenting in the porcine coronary artery model: Differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents. J. Am. Coll. Cardiol., 24 (1994), 525–531.
Hyon, S.H., Jamshidi, K., and Ikada, Y., Effects of residual monomer on the degradation of DL-lactide polymer. Polym. Int., 46 (1998), 196–202.
Isotalo, T., Talja, M., Valimaa, T., Tormala, P., and Tammela, T.L., A bioabsorbable self-expandable, self-reinforced poly-L-lactic acid urethral stent for recurrent urethral strictures: Long-term results. J. Endourol., 16 (2002), 759–762.
Ivanova, T., Grozev, N., Panaiotov, I., and Proust, J.E., Role of the molecular weight and the composition on the hydrolysis kinetics of monolayers of poly(alpha-hydroxy acid)s. Colloid Polym. Sci., 277 (1999), 709–718.
Jeremias, A., Sylvia, B., Bridges, J., et al., Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation, 109 (2004), 1930–1932.
Joshi, A., and Himmelstein, K.J., Dynamics of controlled release from bioerodible matrices. J. Control. Release, 15 (1991), 95–104.
Kastrati, A., Dibra, A., Eberle, S., et al., Sirolimus-eluting stents vs. paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA, 294 (2005), 819–825.
Kastrati, A., Hall, D., and Schomig, A., Long-term outcome after coronary stenting. Curr. Control Trials Cardiovasc. Med., 1 (2000), 48–54.
Katti, D.S., Lakshmi, S., Langer, R., and Laurencin, C.T., Toxicity, biodegradation and elimination of polyanhydrides. Adv. Drug Deliv. Rev., 54 (2002), 933–961.
Khang, G., Rhee, J.M., Jeong, J.K., et al., Local drug delivery system using biodegradable polymers. Macromol. Res., 11 (2003), 207–223.
Kimura, T., Yokoi, H., Nakagawa, Y., et al., Three-year follow-up after implantation of metallic coronary-artery stents. N. Engl. J. Med., 334 (1996), 561–566.
Labinaz, M., Zidar, J.P., Stack, R.S., and Phillips, H.R., Biodegradable stents: The future of interventional cardiology? J. Interv. Cardiol., 8 (1995), 395–405.
Lambert, T.L., Dev, V., Rechavia, E., Forrester, J.S., Litvack F, and Eigler, N.L., Localized arterial wall drug delivery from a polymercoated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin. Circulation, 90 (1994), 1003–1011.
Langer, R., Drug delivery and targeting. Nature, 392 (1998), 5–10.
Laufman, H., and Rubel, T., Synthetic absorbable sutures. Surg. Gynecol. Obstet., 145 (1977), 597–608.
Lemos, P.A., Serruys, P.W., van Domburg, R.T., et al., Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world”: The Rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation, 109 (2004), 190–195.
Levenberg, S., and Langer, R., Advances in tissue engineering. In: Current Topics in Developmental Biology, Vol 61. Elsevier, San Diego (2004) 113.
Li, S.M., and McCarthy, S., Further investigations on the hydrolytic degradation of poly(DL-lactide). Biomaterials, 20 (1999), 35–44.
Li, S.M., and Vert, M., Morphological-Changes Resulting from the hydrolytic degradation of stereocopolymers derived from L-lactides and D1-lactides. Macromolecules, 27 (1994), 3107–3110.
Libby, P., Schwartz, D., Brogi, E., Tanaka, H., and Clinton, S.K., A cascade model for restenosis. A special case of atherosclerosis progression. Circulation, 86 (1992), 11147–11152.
Lincoff, A.M., Fürst, J.G., Ellis, S.G., Tuch, R.J., and Topol, E.J., Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J. Am. Coll. Cardiol., 29 (1997), 808–816.
Lincoff, A.M., Topol, E.J., and Ellis, S.G., Local drug delivery for the prevention of restenosis. Fact, fancy, and future. Circulation, 90 (1994), 2070–2084.
Lipinski, M.J., Fearon, W.F., Froelicher, V.F., and Vetrovec, G.W., The current and future role of percutaneous coronary intervention in patients with coronary artery disease. J. Interv. Cardiol., 17 (2004), 283–294.
Lunt, J., Large-scale production, properties and commercial applications of polylactic acid polymers. Polym. Degradation Stability, 59 (1998), 145–152.
Marx, S.O., Jayaraman, T., Go, L.O., and Marks, A.R., RapamycinFkbp inhibits cell-cycle regulators of proliferation in vascular smoothmuscle cells. Circulation Res., 76 (1995), 412–417.
Middleton, J.C., and Tipton, A.J., Synthetic biodegradable polymers as orthopedic devices. Biomaterials, 21 (2000), 2335–2346.
Mintz, G.S., Hoffmann, R., Mehran, R., et al., In-stent restenosis: The Washington Hospital Center experience. Am. J. Cardiol., 81 (1998), 7E–13E.
Mintz, G.S., Popma, J.J., Pichard, A.D., et al., Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study. Circulation, 94 (1996), 35–43.
Moore, J., Jr., and Berry, J.L., Fluid and solid mechanical implications of vascular stenting. Ann. Biomed. Eng., 30 (2002), 498–508.
Morice, M.C., Serruys, P.W., Sousa, J.E., et al., A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med., 346 (2002), 1773–1780.
Moses, J.W., Leon, M.B., Popma, J.J., et al., Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med., 349 (2003), 1315–1323.
Muller, D.W., Ellis, S.G., and Topol, E.J., Experimental models of coronary artery restenosis. J. Am. Coll. Cardiol., 19 (1992), 418–432.
Murphy, J.G., Schwartz, R.S., Edwards, W.D., Camrud, A.R., Vlietstra RE, and Holmes, D.R., Jr. Percutaneous polymeric stents in porcine coronary arteries. Initial experience with polyethylene terephthalate stents. Circulation, 86 (1992), 1596–1604.
Murphy, J.G., Schwartz, R.S., Huber, K.C., and Holmes, D.R., Jr. Polymeric stents: Modern alchemy or the future? J. Invasive. Cardiol., 3 (1991), 144–148.
Nguyen, K.T., Su, S.H., Sheng, A., et al., In vitro hemocompatibility studies of drug-loaded poly-(L-lactic acid) fibers. Biomaterials, 24 (2003), 5191–5201.
Nguyen, T.Q., and Kausch, H.H., GPC data interpretation in mechanochemical polymer degradation. Int. J. Polym. Anal. Characterization, 4 (1998), 447–470.
Nguyen, T.Q., Kinetics of mechanochemical degradation by gel permeation chromatography. Polym. Degradation Stability, 46 (1994), 99–111.
Nuutinen, J.P., Clerc, C., and Tormala, P., Theoretical and experimental evaluation of the radial force of self-expanding braided bioabsorbable stents. J. Biomater. Sci. Polym. Ed., 14 (2003), 677–687.
Ong, A.T., Serruys, P.W., and Aoki, J., et al., The unrestricted use of paclitaxelversus sirolimus-eluting stents for coronary artery disease in an unselected population: One-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J. Am. Coll. Cardiol., 45 (2005), 1135–1141.
Ottenbrite, R.M., Albertsson, and A.C., Scott, G., Discussion on degradation terminology. In: Vert, M., Feijen, J., Albertsson, A.C., Scott, G., Chiellini, E., Eds. Biodegradable Polymers and Plastics. The Royal Society of Chemisty, Cambridge (1992) 73–92.
Palmaz, J.C., Balloon-expandable intravascular stent. AJR Am. J. Roentgenol., 150 (1988), 1263–1269.
Peng, T., Gibula, P., Yao K.-d., and Goosen, M.F.A., Role of polymers in improving the results of stenting in coronary arteries. Biomaterials, 17 (1996), 685–694.
Peuster, M., Wohlsein, P., Brugmann, M., et al., A novel approach to temporary stenting: Degradable cardiovascular stents produced from corrodible metal-results 6–18 months after implantation into New Zealand white rabbits. Heart, 86 (2001), 563–569.
Pietrzak, W.S., Sarver, D.R., and Verstynen, M.L., Bioabsorbable polymer science for the practicing surgeon. J. Craniofac. Surg., 8 (1997), 87–91.
Pietrzak, W.S., Verstynen, M.L., and Sarver, D.R., Bioabsorbable fixation devices: Status for the craniomaxillofacial surgeon. J. Craniofac. Surg., 8 (1997), 92–96.
Pistner, H., Bendix, D.R., Muhling, J., and Reuther, J.F., Poly (L-Lactide) — A long-term degradation study invivo. 3. Analytical characterization. Biomaterials, 14 (1993), 291–298.
Pistner, H., Gutwald, R., Ordung, R., Reuther, J., and Muhling, J., Poly(L-lactide) — A long-term degradation study in-vivo.l. Biological results. Biomaterials, 14 (1993), 671–677.
Rajagopal, K.R., and Wineman, A.S., A note on viscoelastic materials that can age. Int. J. NonLinear Mech., 39 (2004), 1547–1554.
Robaina, S., Jayachandran, B., He, Y., et al., Platelet adhesion to simulated stented surfaces. J. Endovasc. Tier., 10 (2003), 978–986.
Rogers, C., and Edelman, E.R., Endovascular stent design dictates experimental restenosis and thrombosis. Circulation, 91 (1995), 2995–3001.
Roubin, G.S., Douglas, J.S., Jr., King, S.B., 3rd, et al., Influence of balloon size on initial success, acute complications, and restenosis after percutaneous transluminal coronary angioplasty. A prospective randomized study. Circulation, 78 (1988), 557–565.
Saia, F., Marzocchi, A., and Serruys, P.W., Drug-eluting stents. The third revolution in percutaneous coronary intervention. Ital. Heart J., 6 (2005), 289–303.
Sarembock, I.J., LaVeau, P.J., Sigal, S.L., et al., Influence of inflation pressure and balloon size on the development of intimai hyperplasia after balloon angioplasty. A study in the atherosclerotic rabbit. Circulation, 80 (1989), 1029–1040.
Schakenraad, J.M., Hardonk, M.J., Feijen, J., Molenaar, I., and Nieuwenhuis, P., Enzymatic activity toward poly(L-lactic acid) implants. J. Biomed. Mater. Res., 24 (1990), 529–545.
Schatz, R.A., Baim, D.S., Leon, M., et al., Clinical-experience with the Palmaz-Schatz coronary stent-Initial results of a multicenter study. Circulation, 83 (1991), 148–161.
Schatz, R.A., Introduction to intravascular stents. Cardiol. Clin., 6 (1988), 357–372.
Schnabel, W., Polymer Degradation. Macmillan, New York (1981).
Schofer, J., Schluter, M., Gershlick, A.H., et al., Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet, 362 (2003), 1093–1099.
Schwartz, R.S., Neointima and arterial injury: Dogs, rats, pigs, and more. Lab. Invest., 71 (1994), 789–791.
Schwartz, R.S., Pathophysiology of restenosis: Interaction of thrombosis, hyperplasia, and/or remodeling. Am. J. Cardiol., 81 (1998), 14E–17E.
Serruys, P.W., Dejaegere, P., Kiemeneij, F., et al., A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary-artery disease. N. Engl. J. Med., 331 (1994), 489–495.
Serruys, P.W., Emanuelsson, H., van der Giessen, W., et al., Heparincoated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation, 93 (1996), 412–422.
Siepmann, J., and Gopferich, A., Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv. Drug Delivery Rev., 48 (2001), 229–247.
Sigwart, U., Puel, J., Mirkovitch, V., Joffre, F., and Kappenberger, L., Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N. Engl. J. Med., 316 (1987), 701–706.
Silber, S., Hamburger, J., Grube, E., et al., Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II. Herz, 29 (2004), 171–180.
Siparsky, G.L., Voorhees, K.J., and Miao, F.D., Hydrolysis of polylactic acid (PLA) and polycaprolactone (PCL) in aqueous acetonitrile solutions: Autocatalysis. J. Environ. Polym. Degradation, 6 (1998), 31–41.
Staab, M.E., Holmes, D.R., and Schwartz, R.S., Polymers. In: Sigwart U, Ed. Endoluminal Stenting. WB Saunders, London (1996), 34–44.
Stone, G.W., Ellis, S.G., Cox, D.A., et al., One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation, 109 (2004), 1942–1947.
Su, S.H., Chao, R.Y., Landau, C.L., et al., Expandable bioresorbable endovascular stent. I. Fabrication and properties. Ann. Biomed. Eng., 31 (2003), 667–677.
Tamada, J.A., and Langer, R., Erosion kinetics of hydrolytically degradable polymers. Proceedings of the National Academy of Sciences of the United States of America, 90 (1993), 552–556.
Tamai, H., Igaki, K., Kyo, E., et al., Initial and 6-month results of biodegradable poly-1-lactic acid coronary stents in humans. Circulation, 102 (2000), 399–404.
Tamai, H., Igaki, K., Tsuji, T., et al., A biodegradable poly-L-lactic acid coronary stent in the porcine coronary artery. J. Interven. Cardiol., 12 (1999), 443–449.
Tammela, T.L., and Talja, M., Biodegradable urethral stents. B.JU Int., 92 (2003), 843–850.
Tanabe, K., Serruys, P.W., Grube, E., et al., TAXUS III Trial: Instent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation, 107 (2003), 559–564.
Therasse, E., Soulez, G., Cartier, P., et al., Infection with fatal outcome after endovascular metallic stent placement. Radiology, 192 (1994), 363–365.
Thombre, A.G., Theoretical aspects of polymer biodegradation: Mathematical modeling of drug release and acid-catalyzed poly(othoester) biodegradation. In: Vert, M., Feijen, J., Albertsson, A.C., Scott, G., Chiellini, E., Eds. Biodegradable Polymers and Plastics. The Royal Society of Chemisty, Cambridge (1992) 214–225.
Tsuji, T., Tamai, H., Igaki, K., et al., Biodegradable polymeric stents. Curr. Interv. Cardiol. Rep., 3 (2001), 10–17.
Tsuji, T., Tamai, H., Igaki, K., et al., Biodegradable stents as a platform to drug loading. Int. J. Cardiovasc. Intervent., 5 (2003), 13–16.
Unverdorben, M., Spielberger, A., Schywalsky, M., et al., A polyhydroxybutyrate biodegradable stent: Preliminary experience in the rabbit. Cardiovasc. Intervent. Radiol., 25 (2002), 127–132.
Uurto, I., Mikkonen, J., Parkkinen, J., et al., Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: An experimental pilot study. J. Endovasc. Ther., 12 (2005), 371–379.
Valimaa, T., Laaksovirta, S., Tammela, T.L., et al., Viscoelastic memory and self-expansion of self-reinforced bioabsorbable stents. Biomaterials, 23 (2002), 3575–3582.
van der Giessen, W.J., Lincoff, A.M., Schwartz, R.S., et al., Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation, 94 (1996), 1690–1697.
van der Giessen, W.J., Slager, C.J., Gussenhoven, E.J., et al., Mechanical features and in vivo imaging of a polymer stent. Int. J. Card. Imaging., 9 (1993), 219–226.
van der Giessen, W.J., Slager, C.J., van Beusekom, H.M., et al., Development of a polymer endovascular prosthesis and its implantation in porcine arteries. J. Interv. Cardiol., 5 (1992), 175–185.
van der Giessen, W.J., Vanbeusekom H.M.M., Vanhouten, C.D., Vanwoerkens, L.J., Verdouw, P.D., and Serruys, P.W., Coronary stenting with, polymer-coated and uncoated self-expanding endoprostheses in pigs. Coronary Artery Disease, 3 (1992), 631–640.
Vert, M., Li, S., Garreau, H., et al., Complexity of the hydrolytic degradation of aliphatic polyesters. Angew Makromol Chem., 247 (1997), 239–253.
Vert, M., Li, S.M., Spenlehauer, G., and Guerin, P., Bioresorbability and biocompatibility of aliphatic polyesters. J. Mater. Sci. Mater. Med., 3 (1992), 432–446.
Vert, M., Aliphatic polyesters: Great degradable polymers that cannot do everything. Biomacromolecules, 6 (2005), 538–546.
Virmani, R., Liistro, F., Stankovic, G., et al., Mechanism of late instent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation, 106 (2002), 2649–2651.
Weir, N.A., Buchanan, F.J., Orr, J.F., and Dickson, G.R., Degradation of poly-L-lactide. Part 1: In vitro and in vivo physiological temperature degradation. Proc Inst Mech Eng [H], 218 (2004), 307–319.
Weir, N.A., Buchanan, F.J., Orr, J.F., Farrar, D.F., and Dickson, G.R., Degradation of poly-L-lactide: Part 2: Increased temperature accelerated degradation. Proceedings of the Institution of Mechanical Engineers Part H-J. Eng. Med., 218 (2004), 321–330.
Wentzel, J.J., Krams, R., Schuurbiers, J.C., et al., Relationship between neointimal thickness and shear stress after Wallstent implantation in human coronary arteries. Circulation, 103 (2001), 1740–1745.
Wentzel, J.J., Whelan, D.M., van der Giessen, W.J., et al., Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution. J. Biomech., 33 (2000), 1287–1295.
Whelan, D.M., van Beusekom, H.M., and van der Giessen, W.J., Mechanisms of drug loading and release kinetics. Semin. Interv. Cardiol., 3 (1998), 127–131.
Williams, D.F., Biodegradation of surgical polymers. J. Mater. Sci., 17 (1982), 1233–1246.
Yamawaki, T., Shimokawa, H., Kozai, T., et al., Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. J. Am. Coll. Cardiol., 32 (1998), 780–786.
Ye, Y.W., Landau, C., Willard, J.E., et al., Bioresorbable microporous stents deliver recombinant adenovirus gene transfer vectors to the arterial wall. Ann. Biomed. Eng., 26 (1998), 398–408.
Yoon, J.S., Jin, H.J., Chin, I.J., Kim, C., and Kim, M.N., Theoretical prediction of weight loss and molecular weight during random chain scission degradation of polymers. Polymer, 38 (1997), 3573–3579.
Zahn, R., Hamm, C.W., Schneider, S., et al., Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry). Am. J. Cardiol., 95 (2005), 1302–1308.
Zhang, Y., Zale, S., Sawyer, L., and Bernstein, H., Effects of metal salts on poly(DL-lactide-co-glycolide) polymer hydrolysis. J. Biomed. Mater. Res., 34 (1997), 531–538.
Zidar, J., Lincoff, A., and Stack, R., Biodegradable stents. In: Topol, E.J., Ed. Textbook of Interventional Cardiolology. 2nd ed. WB Saunders, Philadelphia (1994), 787–802.
Zilberman, M., Nelson, K.D., and Eberhart, R.C., Mechanical properties and in vitro degradation of bioresorbable fibers and expandable fiber-based stents. J. Biomed. Mater. Res. B Appl. Biomater., 74 (2005), 792–799.
Zilberman, M., Schwade, N.D., and Eberhart, R.C., Protein-loaded bioresorbable fibers and expandable stents: Mechanical properties and protein release. J. Biomed. Mater. Res. B Appl. Biomater., 69 (2004), 1–10.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Birkhäuser Boston
About this chapter
Cite this chapter
Soares, J.S., Moore, J.E., Rajagopal, K.R. (2007). Theoretical Modeling of Cyclically Loaded, Biodegradable Cylinders. In: Mollica, F., Preziosi, L., Rajagopal, K.R. (eds) Modeling of Biological Materials. Modeling and Simulation in Science, Engineering and Technology. Birkhäuser Boston. https://doi.org/10.1007/978-0-8176-4411-6_4
Download citation
DOI: https://doi.org/10.1007/978-0-8176-4411-6_4
Publisher Name: Birkhäuser Boston
Print ISBN: 978-0-8176-4410-9
Online ISBN: 978-0-8176-4411-6
eBook Packages: EngineeringEngineering (R0)